INZY

Inozyme Pharma

Delisted

INZY was delisted on the 30th of June, 2025.

77 hedge funds and large institutions have $205M invested in Inozyme Pharma in 2023 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 31 increasing their positions, 19 reducing their positions, and 10 closing their positions.

Holders
77
Holders Change
+3
Holders Change %
+4.05%
% of All Funds
1.23%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
13
Increased
31
Reduced
19
Closed
10
Calls
$866K
Puts
$416K
Net Calls
+$450K
Net Calls Change
+$587K
Name Market Value Shares Shares
Change
Shares
Change %
Adage Capital Partners
1
Adage Capital Partners
Massachusetts
$23.3M 5,537,500 +1,287,500 +30%
PBPIA
2
Pivotal bioVenture Partners Investment Advisor
California
$18.9M 4,494,851 +833,333 +23%
SI
3
Sofinnova Investments
California
$18M 4,280,308 +625,000 +17%
RSCM
4
Rock Springs Capital Management
Maryland
$15.5M 3,681,174 +253,090 +7%
SC
5
Samlyn Capital
New York
$13.6M 3,245,208 +3,245,208 New
EAM
6
Eventide Asset Management
Massachusetts
$13.1M 3,125,000 +3,125,000 New
Fidelity Investments
7
Fidelity Investments
Massachusetts
$10.4M 2,465,232 +1,716,398 +229%
NMC
8
NEA Management Company
Maryland
$10.2M 2,437,689
Vanguard Group
9
Vanguard Group
Pennsylvania
$9.56M 2,276,085 +880,175 +63%
BlackRock
10
BlackRock
New York
$9.41M 2,239,742 +300,082 +15%
SB
11
Samsara BioCapital
California
$6.56M 1,562,500 +1,562,500 New
AAA
12
Affinity Asset Advisors
New York
$5.8M 1,379,852 +628,056 +84%
Millennium Management
13
Millennium Management
New York
$5.57M 1,326,871 -879,287 -40%
OCA
14
Octagon Capital Advisors
New York
$5.46M 1,300,000 +1,250,298 +2,516%
CA
15
CHI Advisors
New York
$5.33M 1,270,027 +75,000 +6%
SFM
16
Sphera Funds Management
Israel
$5.19M 1,234,907 +102,940 +9%
Geode Capital Management
17
Geode Capital Management
Massachusetts
$3.46M 822,823 +205,364 +33%
Point72 Asset Management
18
Point72 Asset Management
Connecticut
$2.94M 700,000 +700,000 New
LCM
19
Laurion Capital Management
New York
$2.84M 677,329 +426,961 +171%
State Street
20
State Street
Massachusetts
$2.64M 628,347 +67,505 +12%
DMKJ
21
David M. Knott Jr
$1.91M 454,008 +234,008 +106%
Northern Trust
22
Northern Trust
Illinois
$1.41M 334,647 +34,264 +11%
MB
23
MPM BioImpact
Massachusetts
$1.37M 326,921
SSA
24
Schonfeld Strategic Advisors
New York
$1.31M 311,880 +242,080 +347%
Renaissance Technologies
25
Renaissance Technologies
New York
$1.24M 295,608 +56,408 +24%